Safety and acceptability of cellulose sulfate as a vaginal microbicide in HIV-infected women

AIDS

Volumn 20, Issue 8, 2006, Pages 1109-1116

  El Sadr, Wafaa M ^a,b   Mayer, Kenneth H ^c,d   Maslankowski, Lisa ^e   Hoesley, Craig ^f   Justman, Jessica ^b,g   Gai, Fang ^h   Mauck, Christine ⁱ   Absalon, Judith ^a,b   Morrow, Kathleen ^c   Mâsse, Benoît ^h   Soto Torres, Lydia ^j   Kwiecien, Antonia ^k  

^a HARLEM HOSPITAL CENTER   (United States)

^b Och Spine at New York Presbyterian Hospitals   (United States)

^c MIRIAM HOSPITAL   (United States)

^d Fenway Community Health   (United States)

^e UNIVERSITY OF PENNSYLVANIA   (United States)

^f UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^g BRONX LEBANON HOSPITAL CENTER   (United States)

^h Fred Hutchinson Cancer Research Center   (United States)

ⁱ EASTERN VIRGINIA MEDICAL SCHOOL   (United States)

^j NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^k FAMILY HEALTH INTERNATIONAL   (United States)

more..

Author keywords

Cellulose sulfate; HIV prevention; HIV infected women; Microbicides

Indexed keywords

CELLULOSE SULFATE; MICROBICIDE; PLACEBO;

ABDOMINAL PAIN; ADULT; ARTICLE; BREAKTHROUGH BLEEDING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DRUG SAFETY; ECCHYMOSIS; FEMALE; GEL; GENITAL PAIN; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION SENSITIVITY; MAJOR CLINICAL STUDY; MALE; METRORRHAGIA; PELVIS PAIN SYNDROME; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SEXUAL BEHAVIOR; SEXUALITY; SKIN ABRASION; VAGINA BLEEDING; VAGINITIS;

ABDOMINAL PAIN; ADOLESCENT; ADULT; ANTI-HIV AGENTS; CELLULOSE; DOUBLE-BLIND METHOD; FEMALE; HIV INFECTIONS; HUMANS; HYDROGEN-ION CONCENTRATION; MALE; METRORRHAGIA; MIDDLE AGED; PATIENT COMPLIANCE; PATIENT SATISFACTION; SEXUAL ABSTINENCE; VAGINAL CREAMS, FOAMS, AND JELLIES;

EID: 33646888228     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.aids.0000226950.72223.5f     Document Type: Article

References (23)

1. Women and HIV/AIDS Confronting the Crisis: A joint report by UNAIDS, UNFPA, UNIFEM: Joint United Nations Programme on HIV/AIDS, 2004.
2. Executive Report on the Global AIDS Epidemic: Joint United Nations Programme on HIV/AIDS (UNAIDS), 2004.
3. CDC. Update: Barrier protection against HIV infection and other sexually transmitted diseases. MMWR CDC Surveill Summ 1993. 42:589-597.
4. Stone AB, Hitchcock PJ. Vaginal microbicides for preventing the sexual transmission of HIV. AIDS 1994; 8:S285-S293.
5. Elias CJ, Coggins C. Female-controlled methods to prevent sexual transmission of HIV. AIDS 1996; 10:S43-S51.
6. Elias CJ, Heise LL. Challenges for the development of female-controlled vaginal microbicides. AIDS 1994; 8:1-9.
7. Van Damme L, Alary RC, Vuylsteke M, Chandeying B, Rees V, Sirivongrangson H, et al. Effectiveness of COL-1492, a nonoxynol-9 vaginal gel, on HIV-1 transmission in female sex workers: a randomised controlled trial. Lancet 2002; 360:971-977.
8. Clinical Trials Summary Document: Alliance for Microbicide Development, 2004.
9. CONRAD. Investigators brochure: cellulose sodium sulfate 6% vaginal gel, 2001.
10. Anderson RAZL, Usher TC, inventors, Polydex Pharmaceuticals Ltd, Rush-Presbyterian-St. Luke's Medical Center, assignees. Cellulose sulfate for use as antimicrobial and contraceptive agent. US Patent 6,063,773, 2000 May 16.
11. Yamamoto I, Takayama K, Honma K, Gonda T, Matsuzaki K, Hatana K, et al. Synthesis, structure and antiviral activity of sulfates of cellulose and its branched derivatives. Carbohydrate Polymers 1991; 14:53-63.
12. Astrup TGI, Volkert M. Polysaccharide sulfuric acids as anti-coagulants. Acta Physiol Scand 1944:215-222.
13. Mauck C, Weiner DH, Ballagh S, Creinin M, Archer DF, Schwartz J, et al. Single and multiple exposure tolerance study of cellulose sulfate gel: a Phase I safety and colposcopy study. Contraception 2001; 64:383-391.
14. Malonza I, Mirembe F, Nakabiito C, Odusoga OL, Osinupebi OA, Kamal H, et al. Expanded phase I safety and acceptability trial of 6% cellulose sulfate gel as a vaginal microbicide. In Microbicides 2004. London: 2004.
15. Schwartz J, Mauck C, Lai J, Archer D, Brache V, Creinin M, et al. Phase I 14-day safety and acceptability study of 6% cellulose sulfate. In Microbicides 2004. London: 2004.
16. Mauck C, Frezieres R, Walsh T, Robergeau K. Cellulose sulfate: tolerance and acceptability of penile application. Contraception 2001; 64:377-381.
17. Boom R, Sol CJA, Salimans MM, Jansen CL, Wertheim van Dillen PME, et al. Rapid and simple method for purification of nucleic acids. J Clin Microbiol 2000; 90:495-503.
18. Mayer KH, Karim SA, Kelly C, Maslankowski L, Rees H, Profy AT, et al. Safety and tolerability of vaginal PRO 2000 gel in sexually active HIV-uninfected and abstinent HIV-infected women. AIDS 2003; 17:321-329.
19. Coggins C, Blanchard K, Alvarez F, Brache V, Weisberg E, Kilmarx PH, et al. Preliminary safety and acceptability of a carrageenan gel for possible use as a vaginal microbicide. Sex Transm Infect 2000; 76:480-483.
20. Low-Beer N, Gabe R, McCormack S, Kitchen VS, Lacey CJ, Nunn AJ. Dextrin sulfate as a vaginal microbicide: randomized, double-blind, placebo-controlled trial including healthy female volunteers and their male partners. J Acquir Immune Defic Syndr 2002; 31:391-398.
21. van De Wijgert J, Fullem A, Kelly C, Mehendale S, Rugpao S, Kumwenda N, et al. Phase 1 trial of the topical microbicide BufferGel: safety results from four international sites. J Acquir Immune Defic Syndr 2001; 26:21-27.
22. Priestley CJ, Jones BM, Dhar J, Goodwin L. What is normal vaginal flora? Genitourin Med 1997; 73:23-28.
23. Coggins C, Blanchard K, Friedland B. Men's attitudes towards a potential vaginal microbicide in Zimbabwe, Mexico and the USA. Reprod Health Matters 2000; 8:132-141.